Yahoo Web Search

Search results

    • Q1 2024 Syros Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

      Also in April, the FDA granted Fast Track designation for Tamibarotene in combination with venetoclax and azacitidine for the treatment of newly diagnosed unfit AML with Roger